Does Zantac Cause Kidney Cancer?
Recent research indicates that NDMA-contaminated Zantac may cause kidney cancer, and as many as 18 other types of cancer. If you’ve taken brand-name Zantac and been diagnosed with kidney cancer (or another type of cancer), you may have a claim for compensation, and the experienced Zantac cancer lawyers at Riddle & Brantley may be able to help.
In September 2019, the United States Food and Drug Administration (the FDA) issued an alert that low levels of a contaminant known as NDMA had been detected in Zantac and other ranitidine medicines, which are prescribed to reduce heartburn and excess stomach acid. NDMA is a known carcinogen that can cause kidney cancer and other ailments when ingested at high levels. The active ingredient in Zantac remains effective, but as the FDA alert suggests, the manufacturers and producers of the drug failed in their duty to develop a stable product that is free from potentially dangerous impurities.
For a FREE consultation with an experienced dangerous drug attorney handling Zantac lawsuits, please call 1-800-525-7111.
There is no obligation, and you won’t pay any attorney fees unless we successfully recover compensation for you.
How Do Carcinogenic NDMA Contaminants Get into Zantac?
Pharmaceutical drug scientists have determined that NDMA forms naturally as a result of chemical reactions in certain food and drug products. Increased levels of NDMA form in Zantac and other ranitidine products over time, particularly if the drugs are stored at higher temperatures. Knowing this and the carcinogenic propensities of NDMA, drug manufacturers are obligated to produce a more stable product that does not expose consumers to kidney cancer risks or other related risks.
Consumers that have used Zantac for any length of time should promptly consult with an experienced personal injury lawyer if they have been diagnosed with kidney cancer or any other serious side effects associated with NDMA exposure.
Is Kidney Cancer Linked to Zantac?
While research has not demonstrated a direct causal relationship between NDMA-contaminated Zantac and kidney cancer, what we do know is that NDMA has caused kidney cancer in other studies.
In other words, the Zantac kidney cancer threat is potentially serious.
A landmark report by the Agency for Toxic Substances and Disease Registry determined that laboratory rats exposed to elevated levels of NDMA (such as the type in contaminated Zantac) were more likely to develop kidney cancer.Kidney tumors were also discovered in mice that had ingested elevated levels of NDMA.
The Environmental Protection Agency (EPA) also cautions that NDMA — the dangerous chemical found in Zantac and ranitidine — may cause kidney cancer.
“In animal studies,” an EPA report notes, “exposure to NDMA has caused tumors primarily of the liver, respiratory tract, kidney and blood vessels.”
So, based on the scientific evidence available, it is reasonable to assume that NDMA-contaminated Zantac may cause kidney cancer.
Researchers at Sloan Memorial Cancer Center are reportedly investigating what specific types of cancer, including kidney cancer, may be linked to elevated levels of NDMA. This research will help those who have taken Zantac better understand potential Zantac kidney cancer risk.
Other Cancers Potentially Caused by Zantac
You may be at risk of developing several forms of cancer caused by Zantac impurities, including:
- Kidney cancer
- Liver cancer
- Stomach cancer
- Intestinal cancer
- Colorectal cancer
- Lung cancer
- Pancreatic cancer
- Brain cancer
- Breast cancer
- Prostate cancer
- Uterine cancer
- Ovarian cancer
- Thyroid cancer
- Nasal/throat cancer
- Non-Hodgkins lymphoma
- Multiple myeloma
Have you been diagnosed with kidney cancer (or another type of qualifying cancer) after taking brand-name Zantac?
If you’ve suffered from kidney cancer after taking brand-name Zantac for an extended period of time, you may qualify for a Zantac cancer lawsuit. Significant financial compensation may be available to you.
You may qualify for a Zantac lawsuit if you meet the following criteria:
- Used brand-name Zantac only
- Suffered from at least one of the following cancers:
- Bladder cancer
- Liver cancer
- Stomach cancer
- Esophageal cancer
- Pancreatic cancer
- Must have used brand-name Zantac after October 1984
- Must have used brand-name Zantac for a minimum of one year
- Must have used brand-name Zantac once per week for a minimum of six months
- Must have been diagnosed with a qualifying cancer within 20 years of last dose
- Must not have been a smoker in the past 20 years if diagnosed with lung cancer
- Must be 64 years of age or younger at the time of diagnosis if diagnosed with prostate cancer
Certain other criteria may apply. For a FREE, no-obligation consultation with an experienced Zantac lawsuit attorney, please call 1-800-525-7111.
PLEASE NOTE: At this time, the federal MDL has limited the Zantac claims we can accept to bladder, esophageal, stomach, liver, and pancreatic cancers only. We understand that other cancers may be linked, but we are unfortunately unable to assist with these claims at this time due to evidence and recent court rulings.
The experienced Zantac cancer lawyers at Riddle & Brantley have been helping injured victims get justice and compensation for decades. Our team has successfully recovered damages on behalf of clients who developed cancer as a result of exposure to contaminants, including an $850,000 settlement for a plaintiff whose cancer was caused by asbestos-containing products (see disclaimer below).
We would love to help you and your loved ones if we can.
For a FREE, no-obligation consultation about a potential Zantac lawsuit, please call 1-800-525-7111 or complete the short form below.
There are no upfront costs and we don’t get paid unless we win financial compensation for you.
IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.
“Great experience with great results.”
-Allan H., Riddle & Brantley client
***Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.